OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 05/26/2026 at 18:00, 3 months 30 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en specialiseert zich in farmaceutische onderaannemers in Europa. Toekomstgerichte verklaringen en risico's benadrukt

Transparantiekennisgeving Oxurion NV Farmaceutische Onderaannemers Toekomstgerichte Verklaringen Risico's
BRIEF

published on 05/05/2026 at 18:05, 4 months 20 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities

Transparency Notification Shareholding Atlas Special Opportunities Oxurion Pharmaceutical Subcontractors
BRIEF

published on 05/05/2026 at 18:05, 4 months 20 days ago

Oxurion Réceptionne une Notification de Transparence d'Atlas Special Opportunities

Vente D'actions Atlas Special Opportunities Notification De Transparence Oxurion Secteur Pharmaceutique
BRIEF

published on 05/05/2026 at 18:05, 4 months 20 days ago

Oxurion Receives a Transparency Notification from Atlas Special Opportunities

Transparency Notification Sale Of Shares Atlas Special Opportunities Pharmaceutical Sector Oxurion
BRIEF

published on 05/05/2026 at 18:05, 4 months 20 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities

Actionnariat Notification De Transparence Oxurion Opportunités Spéciales Atlas Sous-traitants Pharmaceutiques
PRESS RELEASE

published on 05/05/2026 at 18:00, 4 months 20 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Het bedrijf specialiseert zich in farmaceutische onderaannemers en bouwt geïntegreerde groep. Toekomstgerichte verklaringen en investeringen in digitale activa benadrukt

Transparantiekennisgeving Oxurion Digitale Activa Toekomstgerichte Verklaringen Farmaceutische
PRESS RELEASE

published on 05/05/2026 at 18:00, 4 months 20 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding the holding of shares. Forward-looking statements and risks mentioned

Forward-looking Statements Transparency Notification Risk Factors Oxurion NV Pharmaceutical Subcontractors
BRIEF

published on 04/30/2026 at 18:35, 4 months 25 days ago

Oxurion publie son rapport annuel 2025 et convoque son assemblée générale des actionnaires

Rapport Annuel Assemblée Générale Des Actionnaires Oxurion Exercice Financier 2025 Externalisation Pharmaceutique
BRIEF

published on 04/30/2026 at 18:35, 4 months 25 days ago

Oxurion Publishes its 2025 Annual Report

General Assembly Health Oxurion Annual Report 2025 Majority Participation
BRIEF

published on 04/30/2026 at 18:35, 4 months 25 days ago

Oxurion Publie son Rapport Annuel 2025

Assemblée Générale Santé Participation Majoritaire Oxurion Rapport Annuel 2025

Published on 09/26/2026 at 01:00, 11 hours 15 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 11 hours 15 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 14 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 18 hours 45 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 21 hours 15 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 07:45, 4 hours 30 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 12 hours 13 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 17 hours 45 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 18 hours ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

View all EQS

Published on 09/26/2026 at 07:00, 5 hours 15 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 18 hours 30 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 18 hours 35 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News